Frequent immunoexpression of TGF-β1, FGF-2 and BMP-2 in fibroblast-like cells in osteofibrous dysplasia

Oncology Reports

Volumn 17, Issue 3, 2007, Pages 531-535

  Sakamoto, Akio ^a   Oda, Yoshinao ^a   Iwamoto, Yukihide ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

BMP 2; FGF 2; Fibrous dysplasia; Osteofibrous dysplasia; TGF 1

Indexed keywords

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BIOSYNTHESIS; CHILD; CLASSIFICATION; COMPARATIVE STUDY; FIBROBLAST; FIBROUS DYSPLASIA; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; BONE MORPHOGENETIC PROTEINS; CHILD; CHILD, PRESCHOOL; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; FIBROUS DYSPLASIA OF BONE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA;

EID: 34247897120     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.3.531     Document Type: Article

References (42)

1. 201codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues. J Mol Diagn 2: 67-72, 2000.
2. Sakamoto A, Oda Y, Iwamoto Y and Tsuneyoshi M: A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to expressions of c-fos and c-jun products and bone matrix proteins: a clinicopathologic review and immunohistochemical study of c-fos, c-jun, type I collagen, osteonectin, osteopontin, and osteocalcin. Hum Pathol 30: 1418-1426, 1999. (Pubitemid 30032916)
3. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P and Gehron Robey P: Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 151: 1587-1600, 1997. (Pubitemid 27527922)
4. Dorfman HD and Czerniak B: Bone Tumors. Mosby, St. Louis, 1998.
5. Marie PJ: Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316: 23-32, 2003.
6. Janssens K, Ten Dijke P, Janssens S and Van Hul W: Transforming growth factor-beta 1 to the bone. Endocr Rev 26: 743-774, 2005.
7. Lerner UH: Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandinun-related but cell proliferation-dependent pathway. J Bone Miner Res 11: 1628-1639, 1996.
8. Pfeilschifter J, Wolf O, Naumann A, Minne HW, Mundy GR and Ziegler R: Chemotactic response of osteoblast-like cells to transforming growth factor beta. J Bone Miner Res 5: 825-830, 1990. (Pubitemid 20294766)
9. Jaye M, Schlessinger J and Dionne CA: Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1135: 185-199, 1992.
10. Basilico C and Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165, 1992.
11. Robinson D, Bab I and Nevo Z: Osteogenic growth peptide regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells. J Bone Miner Res 10: 690-696, 1995.
12. Chaudhary LR and Avioli LV: Extracellular-signal regulated kinase signaling pathway mediates downregulation of type I procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J Cell Biochem 76: 354-359, 2000. (Pubitemid 30078444)
13. Wan M and Cao X: BMP signaling in skeletal development. Biochem Biophys Res Commun 328: 651-657, 2005. (Pubitemid 40208302)
14. Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H and Gross G: Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12: 871-880, 1993. (Pubitemid 24293712)
15. Wang EA, Israel DI, Kelly S and Luxenberg DP: Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9: 57-71, 1993. (Pubitemid 23241842)
16. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS and Kazhdan I: Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161: 218-228, 1994. (Pubitemid 24049169)
17. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM and Rosen V: Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324, 1992.
18. Oreffo RO, Kusec V, Romberg S and Triffitt JT: Human bone marrow osteoprogenitors express estrogen receptor-alpha and bone morphogenetic proteins 2 and 4 mRNA during osteoblastic differentiation. J Cell Biochem 75: 382-392, 1999. (Pubitemid 29521647)
19. Bonewald LF and Dallas SL: Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55: 350-357, 1994. (Pubitemid 24218811)
20. Alliston T, Choy L, Ducy P, Karsenty G and Derynck R: TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20: 2254-2272, 2001. (Pubitemid 32410595)
21. Maeda S, Hayashi M, Komiya S, Imamura T and Miyazono K: Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 23: 552-563, 2004. (Pubitemid 38282387)
22. Canalis E, Economides AN and Gazzerro E: Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218-235, 2003. (Pubitemid 36515285)
23. Yamaguchi A, Komori T and Suda T: Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and cbfa1. Endocr Rev 21: 393-411, 2000. (Pubitemid 32275586)
24. Yamaguchi A, Ishizuya T, Kintou N, et al: Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220: 366-371, 1996. (Pubitemid 26110126)
25. Balint E, Lapointe D, Drissi H, et al: Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J Cell Biochem 89: 401-426, 2003. (Pubitemid 36547274)
26. Chen D, Harris MA, Rossini G, et al: Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 60: 283-290, 1997. (Pubitemid 27106254)
27. Fromigue O, Marie PJ and Lomri A: Bone morphogenetic protein-2 and transforming growth factor-beta 2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 68: 411-426, 1998. (Pubitemid 28080113)
28. Rodan SB, Wesolowski G, Thomas KA, Yoon K and Rodan GA: Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect Tissue Res 20: 283-288, 1989.
29. Nakamura T, Hanada K, Tamura M, et al: Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136: 1276-1284, 1995.
30. Pitaru S, Kotev-Emeth S, Noff D, Kaffuler S and Savion N: Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: enhanced development of mineralized bone-like tissue in culture. J Bone Miner Res 8: 919-929, 1993. (Pubitemid 23219380)
31. Noff D, Pitaru S and Savion N: Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone-like nodules in vitro. FEBS Lett 250: 619-621, 1989. (Pubitemid 19171421)
32. Martin I, Muraglia A, Campanile G, Cancedda R and Quarto R: Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138: 4456-4462, 1997. (Pubitemid 27408494)
33. Pri-Chen S, Pitaru S, Lokiec F and Savion N: Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23: 111-117, 1998. (Pubitemid 28379871)
34. Walsh S, Jefferiss C, Stewart K, Jordan GR, Screen J and Beresford JN: Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone 27: 185-195, 2000. (Pubitemid 30458810)
35. Locklin RM, Williamson MC, Beresford JN, Triffitt JT and Owen ME: In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. Clin Orthop 313: 27-35, 1995.
36. Scutt A and Bertram P: Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int 64: 69-77, 1999. (Pubitemid 29024632)
37. Weinstein LS, Yu S, Warner DR and Liu J: Endocrine manifestations of stimulatory G protein (alpha)-subunit mutations and the role of genomic imprinting. Endocr Rev 22: 675-705, 2001. (Pubitemid 32955250)
38. Riminucci M, Liu B, Corsi A, et al: The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol 187: 249-258, 1999. (Pubitemid 29037056)
39. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR and Vallar L: GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692-696, 1989. (Pubitemid 19214389)
40. Candeliere GA, Roughley PJ and Glorieux FH: Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic Arg201 mutations in G[alpha]s from patients with fibrous dysplasia of bone. Bone 21: 201-206, 1997. (Pubitemid 27395408)
41. Marie PJ, de Pollak C, Chanson P and Lomri A: Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 150: 1059-1069, 1997.
42. Sakamoto A, Oda Y, Oshiro Y, Tamiya S, Iwamoto Y and Tsuneyoshi M: Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia. Hum Pathol 32: 1245-1251, 2001. (Pubitemid 33104437)